甲状腺癌诊疗连续过程中的城乡差异:92,794例病例分析
本研究基于加州癌症登记库等数据,分析1999-2017年92,794例甲状腺癌患者,发现农村和边远地区患者较城市患者诊断时分期更晚、髓样癌和未分化癌发病率更高、更易失访且疾病特异性死亡率更高;农村和边远地区居住是失访的独立相关因素。
要点
- 农村和边远地区患者诊断时远处转移比例高于城市患者(农村56.0 vs 城市50.4/1000新发病例;边远80.9 vs 城市50.4/1000)。
- 农村和边远地区患者失访风险高于城市患者(OR分别为1.69和3.03),疾病特异性死亡风险也更高(OR分别为1.18和1.92)。
- 农村和边远地区居住是失访的独立相关因素,提示失访是差异的关键驱动因素。
核心结论
- 与城市患者相比,农村和边远地区甲状腺癌患者诊断时分期更晚,疾病特异性死亡率更高。
- 农村和边远地区患者更常失访,这为针对性外展以减少结局差异提供了机会。
研究设计与样本
- 研究查询了关联的加州癌症登记库和加州州立健康规划与发展办公室数据库,纳入1999-2017年诊断为甲状腺癌的患者。
- 队列共92,794例:女性65,475例(70.6%),平均年龄50.0岁。
- 分析了城市、农村和边远地区患者诊断时分期、诊断至手术时间、接受适当放射性碘消融、监测状态以及总死亡率和疾病特异性死亡率。
- 采用Cox和逻辑回归模型逐步控制临床和人口学协变量。
- 所有发病率数字均以新诊断病例的比例表示。
主要发现
- 与城市患者相比,农村和边远地区患者更可能为美洲印第安人、白人、无保险和较低社会经济地位五分位数(p < 0.01)。
- 诊断时远处疾病在农村患者(56.0 vs 城市50.4例/1000新发病例,p < 0.01)和边远地区患者(80.9 vs 城市50.4例/1000,p < 0.01)中比城市患者更常见。
- 髓样甲状腺癌发病率在农村患者(17.9 vs 城市13.6例/1000,p < 0.01)和边远地区患者(31.0 vs 城市13.6例/1000,p < 0.01)中高于城市患者。
- 未分化甲状腺癌发病率在边远地区患者中高于城市患者(15.5 vs 7.1例/1000,p < 0.01)。
- 与城市患者相比,农村和边远地区患者更常失访(OR 1.69 [CI 1.54-1.85]和OR 3.03 [CI 1.89-5.26]),疾病特异性死亡率更高(OR 1.18 [CI 1.07-1.30]和OR 1.92 [CI 1.22-2.77])。
临床怎么用
- 农村和边远地区居住是失访的独立相关因素,提示失访是差异的关键驱动因素。
- 作者认为,针对失访的针对性外展可能减少观察到的结局差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: Rurality is associated with higher incidence and higher disease-specific mortality for most cancers. Outcomes for rural and ultrarural ("frontier") patients with thyroid cancer are poorly understood. This study aimed to identify actionable deficits in thyroid cancer outcomes for rural patients. Methods: We queried linked California Cancer Registry and California Office of Statewide Health Planning and Development databases for patients diagnosed with thyroid cancer (1999-2017). We analyzed time from disease stage at diagnosis, time from diagnosis to surgery, receipt of appropriate radioactive iodine ablation, surveillance status, and overall and disease-specific mortality for urban, rural, and frontier patients. Cox and logistic regression models controlled for clinical and demographic covariates a stepwise manner. All incidence figures are expressed as a proportion of newly diagnosed cases. Results: Our cohort comprised 92,794 subjects: (65,475 women [70.6%]; mean age 50.0 years). Compared to urban patients, rural and frontier patients were more likely to be American Indian, White, uninsured, and from lower quintiles of socioeconomic status (p < 0.01). Distant disease at diagnosis was more common in rural (56.0 vs. 50.4 cases per 1000 new cases, p < 0.01) and frontier patients (80.9 vs. 50.4 per 1000, p < 0.01) compared to urban patients. The incidence of medullary thyroid cancer was greater in rural patients (17.9 vs. 13.6 cases per 1000, p < 0.01) and frontier patients (31.0 vs. 13.6 per 1000, p < 0.01) compared to urban patients. The incidence of anaplastic thyroid cancer was higher in frontier versus urban patients (15.5 vs. 7.1 per 1000, p < 0.01). When compared to urban patients, rural and frontier patients were more often lost to follow-up (odds ratio [OR] 1.69 [confidence interval, CI 1.54-1.85], and OR 3.03 [CI 1.89-5.26], respectively) and had higher disease-specific mortality (OR 1.18 [CI 1.07-1.30], and OR 1.92 [CI 1.22-2.77], respectively). Rural and frontier residence was independently associated with being lost to follow-up, suggesting that it is a key driver of disparities. Conclusion: Compared to their urban counterparts, rural and frontier patients with thyroid cancer present with later-stage disease and experience higher disease-specific mortality. They also are more often lost to follow-up, which presents an opportunity for targeted outreach to reduce the observed disparities in outcomes.
引用
- Huston-Paterson HH, Mao Y, Tseng CH, et al. Rural-Urban Disparities in the Continuum of Thyroid Cancer Care: Analysis of 92,794 Cases. Thyroid. 2024. PMID: 38115602. doi:10.1089/thy.2023.0357
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。